NCT02083029
- Conditions
- Asthma, Bronchial Diseases, Consciousness Disorders, +16 more
- Locations
-
- Hull Clinical Trials Unit, Respiratory academic department Cottingham, Yorkshire, United Kingdom
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,959 public trials
737 recruiting studies
Lung Diseases, Obstructive trial results
NCT01360021
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Research Site Huntington Beach, California, United States
- Research Site Long Beach, California, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States
Completed
Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma
NCT00606242
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT02076269
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Edegem, Belgium
NCT02082925
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Clinique du Souffle La Vallonie Lodève, France
NCT02080936
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Clinique du Souffle La Vallonie Lodève, France
NCT02080442
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- West Park Healthcare Center Toronto, Ontario, Canada
NCT02079753
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Servicio de Neumología. Hospital Clínico de San Carlos. Facultad de medicina. Universidad complutense de Madrid Madrid, Spain
NCT00192296
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- MDS Pharma Services New Orleans, Louisiana, United States
Completed
DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)
NCT01868009
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Clearwater, Florida, United States
- GSK Investigational Site Leesburg, Florida, United States